AI-generated summary
The authors developed hybrid vesicles carrying finasteride and gold nanoparticles, built from hair follicle stem cell-derived extracellular vesicles fused with liposomes, and tested them in cells and in an androgenetic alopecia mouse model. They report that once-daily topical gel use led to faster hair follicle transition to the growth phase and greater hair regrowth coverage than 5% minoxidil. The study was conducted in vitro and in mice, so the findings may not apply to humans.
- Who or what was studied
- Androgenetic alopecia mouse model and in vitro hair follicle stem cells
- Limits stated in the abstract
- The evidence comes from cell and mouse experiments, so human effectiveness and safety are not established by this abstract.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Androgenetic alopecia, Low-level laser therapy, Light-emitting diode, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.